Cargando…

Nano-Optogenetic Engineering of CAR T-cells for Precision Immunotherapy with Enhanced Safety

FDA-approved chimeric antigen receptor (CAR) T cell-based immunotherapy has shown curative potential in patients with hematological malignancies. However, owing to the lack of control over the location and duration of anti-tumor immune response, CAR T-cell therapy still faces significant safety chal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Nhung Thi, Huang, Kai, Zeng, Hongxiang, Jing, Ji, Wang, Rui, Fang, Shaohai, Chen, Joyce, Liu, Xin, Huang, Zixian, You, M. James, Rao, Anjana, Huang, Yun, Han, Gang, Zhou, Yubin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678207/ https://www.ncbi.nlm.nih.gov/pubmed/34697491 http://dx.doi.org/10.1038/s41565-021-00982-5

Ejemplares similares

Nano‐optogenetic immunotherapy
por: Huang, Kai, et al.
Publicado: (2022)

Optogenetic Control of Non‐Apoptotic Cell Death
por: He, Lian, et al.
Publicado: (2021)

Optogenetic engineering of STING signaling allows remote immunomodulation to enhance cancer immunotherapy
por: Dou, Yaling, et al.
Publicado: (2023)

Optogenetic engineering to probe the molecular choreography of STIM1-mediated cell signaling
por: Ma, Guolin, et al.
Publicado: (2020)

Near-infrared photoactivatable control of Ca(2+) signaling and optogenetic immunomodulation
por: He, Lian, et al.
Publicado: (2015)

Engineering light-controllable CAR T cells for cancer immunotherapy
por: Huang, Ziliang, et al.
Publicado: (2020)

Red‐shifted optogenetics comes to the spotlight
por: Wang, Tianlu, et al.
Publicado: (2022)

Optophysiology: Illuminating cell physiology with optogenetics
por: Tan, Peng, et al.
Publicado: (2022)

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
por: Burger, Michael C., et al.
Publicado: (2019)

Engineering the next generation of CAR-NK immunotherapies
por: Biederstädt, Alexander, et al.
Publicado: (2021)

Optogenetic Control of Voltage‐Gated Calcium Channels
por: Ma, Guolin, et al.
Publicado: (2018)

Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies
por: Abate-Daga, Daniel, et al.
Publicado: (2014)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Sloas, Christopher, et al.
Publicado: (2021)

Activation-inducible CAR expression enables precise control over engineered CAR T cell function
por: Fraessle, Simon P., et al.
Publicado: (2023)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Optogenetic control of mesenchymal cell fate towards precise bone regeneration
por: Wang, Weicai, et al.
Publicado: (2019)

Temporally precise single-cell resolution optogenetics
por: Shemesh, Or A., et al.
Publicado: (2017)

A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy
por: Valton, Julien, et al.
Publicado: (2015)

Engineering magnetic nano-manipulators for boosting cancer immunotherapy
por: Yan, Bin, et al.
Publicado: (2022)

Allosteric inactivation of an engineered optogenetic GTPase
por: Jain, Abha, et al.
Publicado: (2023)

Bayesian target optimisation for high-precision holographic optogenetics
por: Triplett, Marcus A., et al.
Publicado: (2023)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

An Optogenetic Controllable T Cell System for Hepatocellular Carcinoma Immunotherapy
por: Zhao, Bixing, et al.
Publicado: (2019)

Multiplexed engineering and precision gene editing in cellular immunotherapy
por: Biederstädt, Alexander, et al.
Publicado: (2022)

Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies
por: Mangal, Joslyn L., et al.
Publicado: (2021)

Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
por: Liu, Qiaofei, et al.
Publicado: (2023)

Recent advances in CAR-T cell engineering
por: Huang, Ruihao, et al.
Publicado: (2020)

Engineering CAR T cells for enhanced efficacy and safety
por: Wu, Yiqian, et al.
Publicado: (2022)

Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies
por: Soldierer, Maren, et al.
Publicado: (2022)

Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
por: Schmidt, Dayane, et al.
Publicado: (2022)

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
por: Wu, Xinyu, et al.
Publicado: (2022)

Biomaterials promote in vivo generation and immunotherapy of CAR-T cells
por: Qin, Ya-Ting, et al.
Publicado: (2023)

Advances in CAR T cell immunotherapy for paediatric brain tumours
por: Rao, Padmashree, et al.
Publicado: (2022)

Restoration of visual function by transplantation of optogenetically engineered photoreceptors
por: Garita-Hernandez, Marcela, et al.
Publicado: (2019)

Engineering CAR-T cells
por: Zhang, Cheng, et al.
Publicado: (2017)

Precise Spatiotemporal Control of Optogenetic Activation Using an Acousto-Optic Device
por: Wang, Kaiyu, et al.
Publicado: (2011)

Optogenetic stimulation of G(s)-signaling in the heart with high spatio-temporal precision
por: Makowka, Philipp, et al.
Publicado: (2019)

Spatiotemporally precise optogenetic activation of sensory neurons in freely walking Drosophila
por: DeAngelis, Brian D, et al.
Publicado: (2020)

Self-assembled multifunctional neural probes for precise integration of optogenetics and electrophysiology
por: Zou, Liang, et al.
Publicado: (2021)

Coupling optogenetic stimulation with NanoLuc-based luminescence (BRET) Ca(++) sensing
por: Yang, Jie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ckmqvmiacmi18d30muvu5n96ot